| Ident. | Authors (with country if any) | Title |
|---|
| 000217 |
Avigayil Ribner [Israël] ; Gheona Altarescu [Israël] ; Ari Zimran [Israël] ; Deborah Elstein [Israël] | Osteopontin polymorphic susceptibility factor for Parkinson's disease among patients with Gaucher disease |
| 000264 |
Tamar Shachar [Israël] ; Christophe Lo Bianco [Suisse] ; Alessandra Recchia [Suisse] ; Christoph Wiessner [Suisse] ; Annick Raas-Rothschild [Israël] ; Anthony H. Futerman [Israël] | Lysosomal storage disorders and Parkinson's disease: Gaucher disease and beyond |
| 000285 |
Marica Grskovic [États-Unis] ; Ashkan Javaherian [États-Unis] ; Berta Strulovici [Israël] ; George Q. Daley [États-Unis] | Induced pluripotent stem cells — opportunities for disease modelling and drug discovery |
| 000310 |
Rodrigo Carlessi [Israël] ; Vered Levin-Salomon [Israël] ; Sara Ciprut [Israël] ; Shani Bialik [Israël] ; Hanna Berissi [Israël] ; Shira Albeck ; Yoav Peleg ; Adi Kimchi [Israël] | GTP binding to the ROC domain of DAP‐kinase regulates its function through intramolecular signalling |
| 000328 |
F. Stocchi [Italie] ; J. M. Rabey [Israël] | Effect of rasagiline as adjunct therapy to levodopa on severity of OFF in Parkinson’s disease |
| 000432 |
Adam Zaidel [Israël] ; Alexander Spivak [Israël] ; Benjamin Grieb [Allemagne] ; Hagai Bergman [Israël] ; Zvi Israel [Israël] | Subthalamic span of oscillations predicts deep brain stimulation efficacy for patients with Parkinsons disease |
| 000459 |
Idit Ron [Israël] ; Debora Rapaport [Israël] ; Mia Horowitz [Israël] | Interaction between parkin and mutant glucocerebrosidase variants: a possible link between Parkinson disease and Gaucher disease |
| 000468 |
K. Stumpf ; A. Y. Schumann ; M. Plotnik [Israël] ; F. Gans ; T. Penzel ; I. Fietze ; J. M. Hausdorff [Israël] ; J. W. Kantelhardt [Allemagne] | Effects of Parkinson's disease on brain-wave phase synchronisation and cross-modulation |
| 000586 |
Avner Shahar [États-Unis, Israël] ; Kushang V. Patel [États-Unis] ; Richard D. Semba [États-Unis] ; Stefania Bandinelli [Italie] ; Danit R. Shahar [États-Unis, Israël] ; Louigi Ferrucci [États-Unis] ; Jack M. Guralnik [États-Unis] | Plasma selenium is positively related to performance in neurological tasks assessing coordination and motor speed |
| 000618 |
Anke H. Snijders [Pays-Bas] ; Vivian Weerdesteyn [Pays-Bas] ; Yolien J. Hagen [Pays-Bas] ; Jacques Duysens [Pays-Bas] ; Nir Giladi [Israël] ; Bastiaan R. Bloem [Pays-Bas] | Obstacle avoidance to elicit freezing of gait during treadmill walking |
| 000619 |
Arnaud Delval [France, Pays-Bas] ; Anke H. Snijders [Pays-Bas] ; Vivian Weerdesteyn [Pays-Bas] ; Jacques E. Duysens [Pays-Bas] ; Luc Defebvre [France] ; Nir Giladi [Israël] ; Bastiaan R. Bloem [Pays-Bas] | Objective detection of subtle freezing of gait episodes in Parkinson's disease |
| 000661 |
Adam Zaidel [Israël] ; Hagai Bergman [Israël] ; Ya'Acov Ritov [Israël] ; Zvi Israel Md [Israël] | Levodopa and subthalamic deep brain stimulation responses are not congruent |
| 000696 |
Inbal Maidan [Israël] ; Meir Plotnik [Israël] ; Anat Mirelman [Israël, États-Unis] ; Aner Weiss [Israël] ; Nir Giladi [Israël] ; Jeffrey M. Hausdorff [Israël, États-Unis] | Heart rate changes during freezing of gait in patients with Parkinson's disease |
| 000699 |
Peter Redgrave [Royaume-Uni] ; Manuel Rodriguez [Espagne] ; Yoland Smith [États-Unis] ; Maria C. Rodriguez-Oroz [Espagne] ; Stephane Lehericy [France] ; Hagai Bergman [Israël] ; Yves Agid [France] ; Mahlon R. Delong [États-Unis] ; Jose A. Obeso [Espagne] | Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease |
| 000780 |
Tamar Goren [Israël] ; Liat Adar [Israël] ; Nissim Sasson [Israël] ; Yoni M. Weiss [Israël] | Clinical Pharmacology Tyramine Challenge Study to Determine the Selectivity of the Monoamine Oxidase Type B (MAO‐B) Inhibitor Rasagiline |
| 000915 |
Nir Giladi [Israël] ; Joseph Tal [Israël] ; Tali Azulay [Israël] ; Olivier Rascol [France] ; David J. Brooks [Royaume-Uni] ; Eldad Melamed [Israël] ; Wolfgang Oertel [Allemagne] ; Werner Poewe [Autriche] ; Fabrizio Stocchi [Italie] ; Eduardo Tolosa [Espagne] | Validation of the freezing of gait questionnaire in patients with Parkinson's disease |
| 000A43 |
Robert A. Hauser [États-Unis] ; Mark F. Lew [États-Unis] ; Howard I. Hurtig [États-Unis] ; William G. Ondo [États-Unis] ; Joanne Wojcieszek [États-Unis] ; Cheryl J. Fitzer-Attas [Israël] | Long‐term outcome of early versus delayed rasagiline treatment in early Parkinson's disease |
| 000A50 |
Ruth Djaldetti [Israël] ; Nirit Lev [Israël] ; Eldad Melamed [Israël] | Lesions outside the CNS in Parkinson's disease |
| 000A95 |
Amir Glik [Israël] ; Magdalena Masarwa [Israël] ; Amin Abuful [Israël] ; Amar Deeb [Israël] ; Rosa Strugatsky [Israël] ; Lindsay A. Farrer [États-Unis] ; Robert P. Friedland [États-Unis] ; Rivka Inzelberg [Israël] | Essential tremor might be less frequent than Parkinson's disease in North Israel Arab villages |
| 000B20 |
Adam Zaidel [Israël] ; Alexander Spivak [Israël] ; Lavi Shpigelman [Israël] ; Hagai Bergman [Israël] ; Zvi Israel [Israël] | Delimiting subterritories of the human subthalamic nucleus by means of microelectrode recordings and a Hidden Markov Model |
| 000B22 |
Jeffrey M. Hausdorff [Israël, États-Unis] ; Leor Gruendlinger [Israël] ; Lisa Scollins [États-Unis] ; Siobhan O'Herron [États-Unis] ; Daniel Tarsy [États-Unis] | Deep brain stimulation effects on gait variability in Parkinson's disease |
| 000C29 |
Ilana Schlesinger [Israël] ; Naomi Schlesinger [États-Unis] | Uric acid in Parkinson's disease |
| 000C41 |
Meir Plotnik [Israël] ; Jeffrey M. Hausdorff [Israël, États-Unis] | The role of gait rhythmicity and bilateral coordination of stepping in the pathophysiology of freezing of gait in Parkinson's disease |
| 000D54 |
Nir Giladi [Israël] | Medical treatment of freezing of gait |
| 000E58 |
Meir Plotnik [Israël] ; Nir Giladi [Israël] ; Jeffrey M. Hausdorff [Israël, États-Unis] | Bilateral coordination of walking and freezing of gait in Parkinson’s disease |
| 000E78 |
C. Warren Olanow [États-Unis] ; Robert A. Hauser [États-Unis] ; Joseph Jankovic [États-Unis] ; William Langston [États-Unis] ; Anthony Lang [Canada] ; Werner Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Fabrizio Stocchi [Italie] ; Eldad Melamed [Israël] ; Eli Eyal [Israël] ; Olivier Rascol [France] | A randomized, double‐blind, placebo‐controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): Rationale, design, and baseline characteristics |
| 000F15 |
Yael Manor [Israël] ; Nir Giladi [Israël] ; Alma Cohen [Israël] ; Dan M. Fliss [Israël] ; Jacob T. Cohen [Israël] | Validation of a swallowing disturbance questionnaire for detecting dysphagia in patients with Parkinson's disease |
| 000F37 |
Kallol Ray Chaudhuri [Royaume-Uni] ; Pablo Martinez-Martin [Espagne] ; Richard G. Brown [Royaume-Uni] ; Kapil Sethi [États-Unis] ; Fabrizio Stocchi [Italie] ; Per Odin [Allemagne] ; William Ondo [États-Unis] ; Kazuo Abe [Japon] ; Graeme Macphee [Royaume-Uni] ; Doug Macmahon [Royaume-Uni] ; Paolo Barone [Italie] ; Martin Rabey [Israël] ; Alison Forbes [Royaume-Uni] ; Kieran Breen [Royaume-Uni] ; Susanne Tluk [Royaume-Uni] ; Yogini Naidu [Royaume-Uni] ; Warren Olanow [États-Unis] ; Adrian J. Williams [Royaume-Uni] ; Sue Thomas [Royaume-Uni] ; David Rye [États-Unis] ; Yoshio Tsuboi [Japon] ; Annette Hand [Royaume-Uni] ; Anthony H. V. Schapira [Royaume-Uni] | The metric properties of a novel non‐motor symptoms scale for Parkinson's disease: Results from an international pilot study |
| 000F39 |
Tanya Gurevich [Israël] ; Chava Peretz [Israël] ; Orna Moore [Israël] ; Nina Weizmann [Israël] ; Nir Giladi [Israël] | The effect of injecting botulinum toxin type a into the calf muscles on freezing of gait in Parkinson's disease: A double blind placebo‐controlled pilot study |
| 000F43 |
Robert A. Hauser [États-Unis] ; Olivier Rascol [France] ; Amos D. Korczyn [Israël] ; A. Jon Stoessl [Canada] ; Ray L. Watts [États-Unis] ; Werner Poewe [Autriche] ; Peter P. De Deyn [Belgique] ; Anthony E. Lang [Canada] | Ten‐year follow‐up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa |
| 000F60 |
Nir Giladi [Israël] ; Babak Boroojerdi [Allemagne] ; Amos D. Korczyn [Israël] ; David J. Burn [Royaume-Uni] ; Carl E. Clarke [Royaume-Uni] ; Anthony H. V. Schapira [Royaume-Uni] | Rotigotine transdermal patch in early Parkinson's disease: A randomized, double‐blind, controlled study versus placebo and ropinirole |
| 000F63 |
Jeffrey M. Hausdorff [Israël, États-Unis] ; Justine Lowenthal [Israël] ; Talia Herman [Israël] ; Leor Gruendlinger [Israël] ; Chava Peretz [Israël] ; Nir Giladi [Israël] | Rhythmic auditory stimulation modulates gait variability in Parkinson's disease |
| 001036 |
Orly Weinreb [Israël] ; Tamar Amit [Israël] ; Orit Bar-Am [Israël] ; Moussa B. H. Youdim [Israël] | Induction of Neurotrophic Factors GDNF and BDNF Associated with the Mechanism of Neurorescue Action of Rasagiline and Ladostigil |
| 001052 |
Orna Moore [Israël] ; Chava Peretz [Israël] ; Nir Giladi [Israël] | Freezing of gait affects quality of life of peoples with Parkinson's disease beyond its relationships with mobility and gait |
| 001064 |
Jose M. Rabey [Israël] ; Tatiana Prokhorov [Israël] ; Ala Miniovitz [Israël] ; Eugenia Dobronevsky [Israël] ; Colin Klein [Israël] | Effect of quetiapine in psychotic Parkinson's disease patients: A double‐blind labeled study of 3 months' duration |
| 001075 |
Bruno Dubois [France] ; David Burn [Royaume-Uni] ; Christopher Goetz [États-Unis] ; Dag Aarsland [Norvège] ; Richard G. Brown [Royaume-Uni] ; Gerald A. Broe [Australie] ; Dennis Dickson [États-Unis] ; Charles Duyckaerts [France] ; Jefferey Cummings [États-Unis] ; Serge Gauthier [Canada] ; Amos Korczyn [Israël] ; Andrew Lees (neurologue) [Royaume-Uni] ; Richard Levy [France] ; Irene Litvan [États-Unis] ; Yoshikuni Mizuno [Japon] ; Ian G. Mckeith [Royaume-Uni] ; C. Warren Olanow [États-Unis] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Eduardo Tolosa [Espagne] ; Murat Emre [Turquie] | Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force |
| 001098 |
Murat Emre [Turquie] ; Dag Aarsland [Norvège] ; Richard Brown [Royaume-Uni] ; David J. Burn [Royaume-Uni] ; Charles Duyckaerts [France] ; Yoshikino Mizuno [Japon] ; Gerald Anthony Broe [Australie] ; Jeffrey Cummings [États-Unis] ; Dennis W. Dickson [États-Unis] ; Serge Gauthier [Canada] ; Jennifer Goldman [États-Unis] ; Christopher Goetz [États-Unis] ; Amos Korczyn [Israël] ; Andrew Lees (neurologue) [Royaume-Uni] ; Richard Levy [France] ; Irene Litvan [États-Unis] ; Ian Mckeith [Royaume-Uni] ; Warren Olanow [États-Unis] ; Werner Poewe [Autriche] ; Niall Quinn [Royaume-Uni] ; Christina Sampaio [Portugal] ; Eduardo Tolosa [Espagne] ; Bruno Dubois [France] | Clinical diagnostic criteria for dementia associated with Parkinson's disease |
| 001178 |
Moussa B. H. Youdim [Israël] ; Dale Edmondson [États-Unis] ; Keith F. Tipton [Irlande (pays)] | The therapeutic potential of monoamine oxidase inhibitors |
| 001197 |
Anna L. Bartels [Pays-Bas] ; Bauke M. De Jong [Pays-Bas] ; Nir Giladi [Israël] ; Joanna D. Schaafsma [Pays-Bas] ; R. Paul Maguire [Pays-Bas] ; Lammy Veenma [Pays-Bas] ; Jan Pruim [Pays-Bas] ; Yacov Balash [Israël] ; Moussa B. H. Youdim [Israël] ; Klaus L. Leenders [Pays-Bas] | Striatal dopa and glucose metabolism in PD patients with freezing of gait |
| 001212 |
Kevin M. Biglan [États-Unis] ; Steven Schwid [États-Unis] ; Shirley Eberly [États-Unis] ; Karen Blindauer [États-Unis] ; Stanley Fahn [États-Unis] ; Tamar Goren [Israël] ; Karl Kieburtz [États-Unis] ; David Oakes [États-Unis] ; Sandra Plumb [États-Unis] ; Andrew Siderowf [États-Unis] ; Matthew Stern [États-Unis] ; Ira Shoulson [États-Unis] | Rasagiline improves quality of life in patients with early Parkinson's disease |
| 001221 |
Felix Geser [Autriche] ; Gregor K. Wenning [Autriche] ; Klaus Seppi [Autriche] ; Michaela Stampfer-Kountchev [Autriche] ; Christoph Scherfler [Autriche] ; Martin Sawires [Autriche] ; Carolin Frick [Autriche] ; Jean-Pierre Ndayisaba [Autriche] ; Hanno Ulmer [Autriche] ; Maria T. Pellecchia [Italie] ; Paolo Barone [Italie] ; Hee T. Kim [Royaume-Uni] ; Juzar Hooker [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; Adriana Cardozo [Espagne] ; Eduardo Tolosa [Espagne] ; Michael Abele [Allemagne] ; Thomas Klockgether [Allemagne] ; Karen Stergaard [Danemark] ; Erik Dupont [Danemark] ; Nicole Schimke [Allemagne] ; Karla M. Eggert [Allemagne] ; Wolfgang Oertel [Allemagne] ; Ruth Djaldetti [Israël] ; Werner Poewe [Autriche] | Progression of multiple system atrophy (MSA): A prospective natural history study by the European MSA Study Group (EMSA SG) |
| 001264 |
Rossitza Baltadjieva [Israël] ; Nir Giladi [Israël] ; Leor Gruendlinger [Israël] ; Chava Peretz [Israël] ; Jeffrey M. Hausdorff [Israël, États-Unis] | Marked alterations in the gait timing and rhythmicity of patients with de novo Parkinson's disease |
| 001277 |
Kallol Ray Chaudhuri [Royaume-Uni] ; Pablo Martinez-Martin [Espagne] ; Anthony H. V. Schapira [Royaume-Uni] ; Fabrizio Stocchi [Italie] ; Kapil Sethi [États-Unis] ; Per Odin [Allemagne] ; Richard G. Brown [Royaume-Uni] ; William Koller [États-Unis] ; Paolo Barone [Italie] ; Graeme Macphee [Royaume-Uni] ; Linda Kelly [Royaume-Uni] ; Martin Rabey [Israël] ; Doug Macmahon [Royaume-Uni] ; Sue Thomas [Royaume-Uni] ; William Ondo [États-Unis] ; David Rye [États-Unis] ; Alison Forbes [Royaume-Uni] ; Susanne Tluk [Royaume-Uni] ; Vandana Dhawan [Royaume-Uni] ; Annette Bowron [Royaume-Uni] ; Adrian J. Williams [Royaume-Uni] ; Charles W. Olanow [États-Unis] | International multicenter pilot study of the first comprehensive self‐completed nonmotor symptoms questionnaire for Parkinson's disease: The NMSQuest study |
| 001303 |
Isaac Shpirer [Israël] ; Ala Miniovitz [Israël] ; Colin Klein [Israël] ; Richard Goldstein [Israël] ; Tatiana Prokhorov [Israël] ; Jack Theitler [Israël] ; Lea Pollak [Israël] ; Jose Martin Rabey [Israël] | Excessive daytime sleepiness in patients with Parkinson's disease: A polysomnography study |
| 001314 |
S. Badarny [Israël] ; A. Stern [Israël] ; Z. Susel [Israël] ; S. Honigman [Israël] ; S. Hocherman [Israël] | Effect of ropinirole on visuo‐motor test in newly diagnosed Parkinson's disease patients |
| 001315 |
Daniel Oved [Israël] ; Ilan Ziv [Israël] ; Therese A. Treves [Israël] ; Diana Paleacu [Israël] ; Eldad Melamed [Israël] ; Ruth Djaldetti [Israël] | Effect of dopamine agonists on fatigue and somnolence in Parkinson's disease |
| 001322 |
Olivier Rascol [France] ; David J. Brooks [Royaume-Uni] ; Amos D. Korczyn [Israël] ; Peter P. De Deyn [Belgique] ; Carl E. Clarke [Royaume-Uni] ; Anthony E. Lang [Canada] ; Mona Abdalla [Royaume-Uni] | Development of dyskinesias in a 5‐year trial of ropinirole and L‐dopa |
| 001356 |
Chava Peretz [Israël] ; Talia Herman [Israël] ; Jeffrey M. Hausdorff [Israël, États-Unis] ; Nir Giladi [Israël] | Assessing fear of falling: Can a short version of the Activities‐specific Balance Confidence scale be useful? |
| 001357 |
B. Feldman [Israël] ; J. Chapman [Israël] ; A. D. Korczyn [Israël] | Apolipoprotein ɛ4 advances appearance of psychosis in patients with Parkinson's disease |
| 001395 |
Jean-Jacques Askenasy [Israël] | Trying to understand sleep in Parkinson's disease patients |
| 001400 |
Silvi Frenkel-Toledo [Israël] ; Nir Giladi [Israël] ; Chava Peretz [Israël] ; Talia Herman [Israël] ; Leor Gruendlinger [Israël] ; Jeffrey M. Hausdorff [Israël, États-Unis] | Treadmill walking as an external pacemaker to improve gait rhythm and stability in Parkinson's disease |
| 001436 |
Moussa B. H. Youdim [Israël] ; Orit Bar Am [Israël] ; Merav Yogev-Falach [Israël] ; Orly Weinreb [Israël] ; Wakako Maruyama [Japon] ; Makato Naoi [Japon] ; Tamar Amit [Israël] | Rasagiline: Neurodegeneration, neuroprotection, and mitochondrial permeability transition |
| 001453 |
Orly Weinreb [Israël] ; Tamar Amit [Israël] ; Orit Bar-Am [Israël] ; Orly Chillag-Talmor [Israël] ; Moussa B. H. Youdim [Israël] | Novel Neuroprotective Mechanism of Action of Rasagiline Is Associated with Its Propargyl Moiety: Interaction of Bcl‐2 Family Members with PKC Pathway |
| 001473 |
Meir Plotnik [Israël] ; Nir Giladi [Israël] ; Yacov Balash [Israël] ; Chava Peretz [Israël] ; Jeffrey M. Hausdorff [Israël, États-Unis] | Is freezing of gait in Parkinson's disease related to asymmetric motor function? |
| 001490 |
Silvia Mandel [Israël] ; Edna Grunblatt [Allemagne] ; Peter Riederer [Allemagne] ; Ninette Amariglio [Israël] ; Jasmine Jacob Hirsch [Israël] ; Gideon Rechavi [Israël] ; Moussa B. H. Youdim [Israël] | Gene Expression Profiling of Sporadic Parkinson's Disease Substantia Nigra Pars Compacta Reveals Impairment of Ubiquitin‐Proteasome Subunits, SKP1A, Aldehyde Dehydrogenase, and Chaperone HSC‐70 |
| 001503 |
Galit Yogev [Israël] ; Nir Giladi [Israël] ; Chava Peretz [Israël] ; Shmuel Springer [Israël] ; Ely S. Simon [États-Unis] ; Jeffrey M. Hausdorff [Israël, États-Unis] | Dual tasking, gait rhythmicity, and Parkinson's disease: Which aspects of gait are attention demanding? |
| 001600 |
Rinat Tabakman [Israël] ; Shimon Lecht [Israël] ; Philip Lazarovici [Israël] | Neuroprotection by monoamine oxidase B inhibitors: a therapeutic strategy for Parkinson's disease? |
| 001605 |
Christopher G. Goetz [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Royaume-Uni] ; Glenn T. Stebbins [États-Unis] ; Carl Counsell [Portugal] ; Nir Giladi [Israël] ; Robert G. Holloway [États-Unis] ; Charity G. Moore [États-Unis] ; Gregor K. Wenning [Autriche] ; Melvin D. Yahr [États-Unis] ; Lisa Seidl [États-Unis] | Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease |
| 001613 |
C. Warren Olanow [États-Unis] ; Yves Agid [France] ; Yoshi Mizuno [Japon] ; Alberto Albanese [Italie] ; U. Bonucelli [Italie] ; Philip Damier [France] ; Justo De Yebenes [Espagne] ; Oscar Gershanik [Argentine] ; Mark Guttman [Canada] ; F. Grandas [Espagne] ; Mark Hallett [États-Unis] ; Ole Hornykiewicz [Autriche] ; Peter Jenner [Royaume-Uni] ; R. Katzenschlager [Royaume-Uni] ; William J. Langston [États-Unis] ; Peter Lewitt [États-Unis] ; Eldad Melamed [Israël] ; M. A. Mena [Espagne] ; P. P. Michel [France] ; Catherine Mytilineou [États-Unis] ; Jose A. Obeso [Espagne] ; Werner Poewe [Autriche] ; Niall Quinn [Royaume-Uni] ; R. Raisman-Vozari [France] ; Ali H. Rajput [Canada] ; Olivier Rascol [France] ; Christina Sampaio [Portugal] ; Fabrizio Stocchi [Italie] | Levodopa in the treatment of Parkinson's disease: Current controversies |
| 001616 |
Moussa B. H. Youdim [Israël] ; Galia Stephenson [Israël] ; Dorit Ben Shachar [Israël] | Ironing Iron Out in Parkinson's Disease and Other Neurodegenerative Diseases with Iron Chelators: A Lesson from 6‐Hydroxydopamine and Iron Chelators, Desferal and VK‐28 |
| 001617 |
Luigi Zecca [Italie] ; Moussa B. H. Youdim [Israël] ; Peter Riederer [Allemagne] ; James R. Connor [États-Unis] ; Robert R. Crichton [Belgique] | Iron, brain ageing and neurodegenerative disorders |
| 001634 |
Bastiaan R. Bloem [Pays-Bas] ; Jeffrey M. Hausdorff [Israël, États-Unis] ; Jasper E. Visser [Pays-Bas] ; Nir Giladi [Israël] | Falls and freezing of gait in Parkinson's disease: A review of two interconnected, episodic phenomena |
| 001765 |
Orly Weinreb [Israël] ; Silvia Mandel [Israël] ; Moussa B. H. Youdim [Israël] | Gene and Protein Expression Profiles of Anti‐ and Pro‐apoptotic Actions of Dopamine, R‐Apomorphine, Green Tea Polyphenol (−)‐Epigallocatechine‐3‐gallate, and Melatonin |
| 001766 |
Judit Várkonyi [Hongrie] ; Hanna Rosenbaum [Israël] ; Nicole Baumann [France] ; Jennifer J. Mackenzie [Canada] ; Zsuzsa Simon [Hongrie] ; Judith Aharon-Peretz [Israël] ; Jamie M. Walker [États-Unis] ; Nahid Tayebi [États-Unis] ; Ellen Sidransky [États-Unis] | Gaucher disease associated with parkinsonism: Four further case reports |
| 001820 |
Tamar C. Rubinstein [Israël] ; Nir Giladi [Israël] ; Jeffrey M. Hausdorff [Israël, États-Unis] | The power of cueing to circumvent dopamine deficits: A review of physical therapy treatment of gait disturbances in Parkinson's disease |
| 001857 |
Hagai Bergman [Israël] ; Günther Deuschl [Allemagne] | Pathophysiology of Parkinson's disease: From clinical neurology to basic neuroscience and back |
| 001932 |
Galit Pelled [Israël] ; Hagai Bergman [Israël] ; Gadi Goelman [Israël] | Bilateral overactivation of the sensorimotor cortex in the unilateral rodent model of Parkinson's disease – a functional magnetic resonance imaging study |
| 001959 |
Yossi Gilgun-Sherki [Israël] ; Eldad Melamed [Israël] ; Daniel Offen [Israël] | Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier |
| 001975 |
Drora Fraser [Israël] ; Noga Givon-Lavi ; Bilenko Natalya ; Ron Dagan | A Decade (1989–1998) of Pediatric Invasive Pneumococcal Disease in 2 Populations Residing in 1 Geographic Location: Implications for Vaccine Choice |
| 001A10 |
Moussa B. H. Youdim [Israël] ; A. Wadia [États-Unis] ; W. Tatton [États-Unis] ; Marta Weinstock [Israël] | The Anti‐Parkinson Drug Rasagiline and Its Cholinesterase Inhibitor Derivatives Exert Neuroprotection Unrelated to MAO Inhibition in Cell Culture and in Vivo |
| 001A13 |
Howard Tandeter [Israël] ; Amalia Levy [Israël] ; Guy Gutman [Israël] ; Pesach Shvartzman [Israël] | Subclinical thyroid disease in patients with Parkinson's disease |
| 001A64 |
Ruth Hardoff [Israël] ; Michael Sula [Israël] ; Ada Tamir [Israël] ; Adrian Soil [Israël] ; Avi Front [Israël] ; Samich Badarna [Israël] ; Silvia Honigman [Israël] ; Nir Giladi [Israël] | Gastric emptying time and gastric motility in patients with Parkinson's disease |
| 001A65 |
N. Giladi [Israël] ; H. Shabtai [Israël] ; E. Rozenberg [Israël] ; E. Shabtai [Israël] | Gait festination in Parkinson's disease |
| 001A90 |
Alberto Albanese [Italie] ; Ubaldo Bonuccelli [Italie] ; Christine Brefel [France] ; K. Ray Chaudhuri [Royaume-Uni] ; Carlo Colosimo [Italie] ; Tobias Eichhorn [Allemagne] ; Eldad Melamed [Israël] ; Pierre Pollak [France] ; Teus Van Laar [Pays-Bas] ; Mario Zappia [Italie] | Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease |
| 001B09 |
J.-J. M Askenasy [Israël] | Approaching disturbed sleep in late Parkinson's Disease: first step toward a proposal for a revised UPDRS |
| 001D32 |
M. Nussbaum [Israël] ; T. A. Treves [Israël] ; R. Inzelberg [Israël] ; J. M. Rabey [Israël] ; A. D. Korczyn [Israël] | Survival in Parkinson's disease: the effect of dementia |
| 001E05 |
Bernard Belhassen [Israël] ; Sami Viskin [Israël] ; Roman Fish [Israël] ; Aharon Glick [Israël] ; Michael Glikson [Israël] ; Michael Eldar [Israël] | Catheter-induced mechanical trauma to accessory pathways during radiofrequency ablation: incidence, predictors and clinical implications |
| 001E63 |
Rascol [France] ; David J. Brooks [Royaume-Uni] ; Ehrout R. Brunt [Pays-Bas] ; Amos D. Korczyn [Israël] ; Warner H. Poewe [Autriche] ; Fabrizzio Stocchi [Italie] | Ropinirole in the treatment of early Parkinson's disease: A 6‐month interim report of a 5‐year levodopa‐controlled study |
| 001F50 |
R. E Lubow [Israël] | Latent inhibition as a measure of learned inattention: some problems and solutions |
| 001F95 |
Avissar [Israël] ; Liza Barki-Harrington [Israël] ; Yuval Herishanu [Israël] ; Gabriel Schreiber [Israël] | Reduced Gs protein function and Gαs levels in leukocytes of patients with Parkinson's disease |
| 002087 |
O. Neudorfer [Israël] ; N. Giladi [Israël] ; D. Elstein [Israël] ; A. Abrahamov [Israël] ; T. Turezkite [Israël] ; E. Aghai [Israël] ; A. Reches [Israël] ; B. Bembi [Israël] ; A. Zimran [Israël] | Occurrence of Parkinson's syndrome in type 1 Gaucher disease |
| 002337 |
Irit Gordon [Israël] ; Ronit Weizman [Israël] ; Ella Rosenne [Israël] ; Moshe Rehavi [Israël] | Developmental and age-related alterations in rat brain presynaptic dopaminergic mechanisms |
| 002461 |
G. Ron [Israël] ; Yair Mordish [Israël] ; Avi Eisenthal [Israël] ; Yehuda Skornick [Israël] ; J. Inbar [Israël] ; Samario Chaitchik [Israël] | A phase II study of combined administration of dacarbazine and carboplatin with home therapy of recombinant interleukin-2 and interferon-α2a in patients with advanced malignant melanoma |
| 002504 |
Youdim [Israël] ; D. Ben-Shachar [Israël] ; P. Riederer [Allemagne] | The possible role of iron in the etiopathology of parkinson's disease |
| 002552 |
H. Youdim [Israël] ; P. Riederer [Allemagne] | Dopamine metabolism and neurotransmission in primate brain in relationship to monoamine oxidase A and B inhibition |
| 002640 |
D. Adam [Israël] ; S. Gilat [Israël] | Classification of pathologies by reduced sequential potential maps |
| 002665 |
Manfred Gerlach [Allemagne] ; Peter Riederer [Allemagne] ; Horst Przuntek [Allemagne] ; Moussa B. H. Youdim [Israël] | MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease |
| 002744 |
J. M. Rabey [Israël] ; M. Scharf [Israël] ; Z. Oberman [Israël] ; M. Zohar [Israël] ; E. Graff [Israël] | Cortisol, ACTH, and beta-endorphin after dexamethasone administration in Parkinson's dementia |
| 002787 |
K. Jellinger [Autriche] ; W. Paulus [Autriche] ; I. Grundke-Iqbal [États-Unis] ; P. Riederer [Allemagne] ; H. Youdim [Israël] | Brain iron and ferritin in Parkinson's and Alzheimer's diseases |
| 002841 |
Boris Strasberg [Israël] ; Alex Sagie [Israël] ; Eldad Rechavia [Israël] ; Amos Katz [Israël] ; A. Ovsyscher [Israël] ; Samuel Sclarovsky [Israël] ; Jacob Agmon [Israël] | Deleterious effects of intravenous verapamil in Wolff-Parkinson-White patients and atrial fibrillation |
| 002869 |
H. Youdim [Israël] | Platelet monoamine oxidase B: Use and misuse |
| 002877 |
E. Sofic [Allemagne] ; P. Riederer [Allemagne] ; H. Heinsen [Allemagne] ; H. Beckmann [Allemagne] ; P. Reynolds [Royaume-Uni] ; G. Hebenstreit [Autriche] ; H. Youdim [Israël] | Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain |
| 002929 |
R. Inzelberg [Israël] ; T. Treves [Israël] ; I. Reider [Israël] ; I. Gerlenter [Israël] ; D. Korczyn [Israël] | Computed tomography brain changes in Parkinsonian dementia |
| 002965 |
Jankovic [États-Unis] ; Avi Reches [Israël] | Parkinson's disease in monozygotic twins |
| 002979 |
S. Elizan [États-Unis] ; Hava Sroka [Israël] ; H. Maker [États-Unis] ; H. Smith [États-Unis] ; D. Yahr [États-Unis] | Dementia in idiopathic Parkinson's disease |
| 002A13 |
W. Birkmayer [Autriche] ; J. Knoll [Hongrie] ; P. Riederer [Autriche] ; H. Youdim [Israël] ; Vera Hars [Hongrie] ; J. Marton [Hongrie] | Increased life expectancy resulting from addition of l-deprenyl to Madopar® treatment in Parkinson's disease: A longterm study |
| 002A14 |
I. Steiner [Israël] ; M. Gomori [Israël] ; E. Melamed [Israël] | Features of brain atrophy in Parkinson's disease |
| 002B81 |
W. Birkmayer [Autriche] ; P. Riederer [Autriche] ; M. B. H. Youdim [Israël] | Distinction between benign and malignant type of parkinson's disease |
| 002B88 |
J. Vardi [Israël] ; H. Glaubman [Israël] ; J. Rabey [Israël] ; M. Streifler [Israël] | EEG sleep patterns in Parkinsonian patients treated with Bromocryptine and L-Dopa: A comparative study |
| 002B96 |
B. Blum [Israël] ; R. Segal [Israël] ; G. Shtacher [Israël] ; B. Shohat [Israël] | Spasticity phenomena caused by N-substituted phenylalanine |
| 002B99 |
H. Belmaker [Israël] ; P. Ebstein [Israël] ; J. Biederman [Israël] ; R. Stern [Israël] ; M. Berman [Israël] ; M. Van Praag [Israël] | The effect of l -dopa and propranolol on human CSF cyclic nucleotides |
| 002C03 |
J. Vardi [Israël] ; H. Glaubman [Israël] ; M. Rabey [Israël] ; M. Streifler [Israël] | Myoclonic attacks induced by L-Dopa and Bromocryptin in Parkinson patients |
| 002C35 |
J. Wajsbort [Israël] | Zur Frage des Off-On-Effektes bei Levodopa-Behandlung des Parkinsonismus |
| 002C38 |
Arnold J. Rosin [Israël] | THE PROBLEMS OF MOTOR NEURONE DISEASE |
| 002D07 |
J. Chaco [Israël] ; O. Abramsky [Israël] | The effect of L-DOPA on postural reflexes in parkinson's disease |
| 002D42 |
J. Munk [Israël] ; A. Rosenberger [Israël] | The radiological manifestations of the initial phases of rheumatic carditis in childhood |
